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Abstract Stromal myofibroblasts (SMF) associated with
various types of carcinomas are believed to emerge under
the influence of the tumor cells. Recent studies have shown
that SMF may originate from fibroblasts within the tumor
stroma or even from carcinoma cells by the process of
epithelial-mesenchymal transition. The aim of this study
was to investigate the concomitant expression of epithelial
membrane antigen and α-smooth muscle actin in cells at
the tumor-connective tissue interface in human tongue
carcinoma, as a possible reflection of epithelial-
mesenchymal transition. Given its key role in this process,
expression of transforming growth factor-β in the malig-
nant cells was assessed as well. Immunostaining with α-
smooth muscle actin was performed on cases of hyperplasia
(n=16), mild dysplasia (n=12), moderate-to-severe dyspla-
sia (n=11) and carcinoma (n=22). Transforming growth
factor-β assessment and double immunostaining with
epithelial membrane antigen and α-smooth muscle actin
were performed only in cases of carcinoma. SMF were
significantly associated with carcinomas, while their num-
ber in pre-malignant lesions (hyperplasia and dysplasia)
was significantly lower (P<0.001). Although SMF were
found in all carcinomas, they were heterogeneous in their
frequency and patterns of distribution. In addition, 95% of
the carcinomas expressed transforming growth factor-β and
41% exhibited cells positive for both epithelial membrane
antigen and α-smooth muscle actin. SMF were almost
exclusively associated with established carcinomas and not
with pre-malignant lesions. Cells that co-expressed epithe-
lial membrane antigen and α-smooth muscle actin can be a
manifestation of epithelial-mesenchymal transition and, as
such, may serve as a source for SMF in these tumors. These
findings appear to be linked to the frequent expression of
transforming growth factor-β by the malignant cells.
Keywords Epithelial-mesenchymaltransition.Stromal
myofibroblasts.Tonguecarcinoma.Transforminggrowth
factor-β
Introduction
Oral cancer has consistently ranked among the top ten
cancers worldwide with more than 300,000 new cases
diagnosed each year [1, 2]. Despite the recently reported
drop in the overall death rate from cancer, the estimated
survival rate (~50%) and number of deaths from oral cancer
remain virtually unchanged [2]. Over 90% of oral cancers
are of the squamous cell carcinoma type.
Solid tumors, such as oral squamous cell carcinoma,
have been increasingly perceived as a composite of cancer
cells and stromal cells (e.g., fibroblasts, endothelial cells
and inflammatory cells) that work in concert towards tumor
progression, angiogenesis, local invasion and metastases
[3]. It is gradually becoming clearer that of all the stromal
cells, the fibroblasts are prominent modifiers of cancer
progression [4, 5]. Our knowledge about these cells is still
evolving, but evidence has been accumulating on a
subpopulation of fibroblasts, called “activated fibroblasts”
with regard to their role in tumor growth and progression
[3, 6].
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Tel Hashomer, IsraelIn the early growth stages of epithelial tumors, the
neoplasia is embedded in the stroma of a given tissue,
which, under the influence of the growth factors secreted by
the cancer cells themselves, becomes a “reactive stroma”
that is remarkable for its increased number of fibroblasts
and enhanced capillary density [3, 7]. Under these
conditions, original normal stromal fibroblasts become
“activated” and a number of them develop a modified
phenotype, similar to that of fibroblasts associated with
wound healing, and one which features the expression of α-
smooth muscle actin. This phenotype is compatible with
that of myofibroblasts [8]. The signals that mediate the
transition of fibroblasts into stromal myofibroblasts (SMF)
are the subject of ongoing investigations. Currently, trans-
forming growth factor-β is the leading mediator known to
be involved in this transition [9, 10].
In addition to the transition of stromal fibroblasts into
SMF, the latter are believed to arise from other origins.
Recent studies point to a possible origin from the bone
marrow and periadventitial cells (e.g., pericytes and
vascular smooth muscle cells) [7]. There is also emerging
evidence that the malignant epithelial cells themselves may
be a significant source for these cells [11].This phenome-
non is termed epithelial-mesenchymal transition during
which epithelial cells lose their specific markers and
acquire the characteristics of mesenchymal cells [12, 13].
Epithelial-mesenchymal transition, originally described
during embryogenesis [12–14], is currently believed to be
involved in tumor development and progression [15, 16].
Most notably, down-regulation of epithelial markers (e.g., E
(epithelial)-cadherin) concomitant with increased expres-
sion of mesenchymal markers (e.g., vimentin) and gain of a
fibroblastoid morphology together with an increased inva-
sive potential have been described in oral squamous cell
carcinoma cell lines [17, 18]. Furthermore, down-regulation
of E-cadherin expression has been recently associated with
poor prognosis in oral squamous cell carcinoma patients
[19]. Finally, transforming growth factor-β is considered as
playing a key role in the epithelial-mesenchymal transition
process as well [11–13].
In our previous study using a 4-nitroquinoline 1-oxide-
induced rat tongue carcinoma model, we showed that the
appearance of SMF was closely associated with the
development of carcinoma but not with pre-malignant
lesions [20]. Furthermore, on an ultrastructural level, we
showed that the carcinoma cells, but not their normal
counterparts, acquired cytoplasmic microfilaments that
were consistent with contractile microfilaments both in
appearance and organization [21]. These events reflect the
morphological modifications occurring within the malig-
nant cells, approaching smooth muscle differentiation,
probably as part of the epithelial-mesenchymal transition
process.
The purpose of the present study was to examine the
changes in the occurrence of SMF in tongue epithelial
lesions with malignant potential (hyperplasia and dysplasia)
and in squamous cell carcinoma, and to assess the
expression of transforming growth factor-β in cases of
carcinoma. In addition, we attempted to identify the
presence of carcinoma cells that co-express epithelial
membrane antigen and α-smooth muscle actin as a
reflection of the epithelial-mesenchymal transition process
using a double immunostaining method, which was not
previously reported in studies on oral cancer in this context.
Materials and Methods
Study Group
Study Population
Records of 22 cases of squamous cell carcinoma of the
tongue and 39 cases of premalignant lesions of the tongue
consisting of hyperplasia (N=16), mild dysplasia (N=12),
and moderate-to-severe dysplasia (N=11) were retrieved
from the files of the Department of Oral Pathology, School
of Dental Medicine, Tel-Aviv University and Institute of
Pathology, The Chaim Sheba Medical Center, Tel
Hashomer. Diagnoses were reevaluated and classified by
two oral pathologists (MVand DD) according to the World
Health Organization classification of head and neck tumors
[22]. This study was approved by the Helsinki committee of
the Sheba Medical Center.
Immunohistochemical Stains
Three µ wide sections had been cut from the 61 blocks
containing the biopsy specimens of the study cases. They
were mounted on positive-charged microscope slides
(Optiplus
TM, Biogenex, San Ramon, CA, USA), dewaxed
in xylene, dehydrated in ethanol, rinsed in distilled water,
placed in 3% H2O2, and rinsed again in distilled water. The
slides were placed in citrate buffer solution, pH=6, in a
microwave oven at 92°C for 10 min for retrieval of
antigens. After cooling, the slides were exposed to the
primary α-smooth muscle actin antigen (clone 1A4, 1:100,
Dako A/S, Denmark) for 60 min at room temperature. They
were then rinsed in phosphate buffered saline (PBS). The
universal immune peroxidase polymer anti-mouse rabbit
Histofine® (Multi) kit (Nichirei, Tokyo, Japan) was used
for the detection of antibodies. The sections were rinsed in
PBS, reacted with an amino ethyl-carbazole (AEC) sub-
strate chromogen kit (Zymed, San Francisco, CA, USA),
rinsed in PBS, counterstained in Mayer’s hematoxylin
(Pioneer Research Chemicals, Colchester, UK) and covered
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(Zymed, San Francisco, CA, USA). Positive control tissues
comprised of bowel wall for α-smooth muscle actin, breast
for epithelial membrane antigen and placenta for trans-
forming growth factor-β. Negative controls were achieved
by performing the staining procedures with omission of the
primary antibody.
Only the squamous cell carcinoma sections were
submitted to additional immunostaining by transforming
growth factor-β (1:25, LabVision, Fremont, CA, USA) and
double staining with α-smooth muscle actin and epithelial
membrane antigen (clone ZCE 113, 1:50, Zymed, San
Francisco, CA, USA), employing a double chromogen
reaction, where the former was visualized by 3,3′-diamino-
benzidine (DAB) and the latter by Fast-Red (Biocare,
Concord, CA, USA). Epithelial membrane antigen was
chosen as a marker for epithelial differentiation [23] using a
typical membranous cellular localization to discriminate it
from cytoplasmic α-smooth muscle actin positivity.
Immunomorphometric Assessment of the α-Smooth
Muscle Actin-Stained SMF
The method employed in the present study was used by us
previously [20]. In brief, a 100-square grid (Olympus,
Tokyo, Japan) was mounted on the microscope. Each
crossing between a horizontal and vertical line was termed
as an “intersection”. At x400 magnification, the grid was
located on the left border of the tissue, immediately beneath
the epithelium, where its upper border tangentially touched
the tip of the adjacent epithelial rete ridges. The α-smooth
muscle actin-stained cells, compatible with myofibroblasts,
were counted within the connective tissue covered by the 3
rows of the grid (30 squares, 44 intersections) closest to the
epithelium. According to the point-counting method, the α-
smooth muscle actin-stained cells that overlapped an
intersection in the established area were counted, excluding
all positively stained cells in the blood vessel walls. When
counting of the first field was completed, the grid was
moved to the next field, using the peripheral border of the
grid as the reference point. A total of 10 representative
fields were counted in each case. For areas containing
carcinoma, the fields were counted at the periphery of the
tumor islands at the invasive front. The number of α-
smooth muscle actin-stained cells overlapping intersections
in the 10 fields in each case was summed up and expressed
as the percentage of the total number of intersections (i.e.,
440). The results were expressed as the mean percentage of
α-smooth muscle actin-stained cells per intersection in each
study group. For example, the mean percentage of α-
smooth muscle actin-stained cells per intersection in the 22
cases of the squamous cell carcinoma group was calculated
as follows: all α-smooth muscle actin-positive intersections
in 10 fields were summed up and divided by 440. The
results of all these 22 cases were added together, divided by
22 and multiplied by 100.
Pattern of Distribution of the SMF in Cases of Squamous
Cell Carcinoma
The immunohistochemically stained squamous cell carci-
noma slides were examined for the pattern of distribution of
the SMF. The cases were classified according to two
dominant patterns: “spindle” and “network”. In the “spin-
dle” pattern, visualization at low and medium power
revealed stromal α-smooth muscle actin-stained myofibro-
blasts with a spindle-shape morphology tightly adhering to
the periphery of the carcinoma islands/nests in one-to-three
concentric layers. In the “network” pattern, SMF were
exceptionally abundant and had a plump appearance, and
their proportion occasionally exceeded that of the carcino-
matous component. They were organized in short-to
medium-length intersecting bundles and, at a higher
magnification, their high density gave the impression of
multilayering, thus the term “network”.
Staining Pattern of Transforming Growth Factor-β
in Squamous Cell Carcinoma
Expression of transforming growth factor-β was assessed
semi-quantitatively, where positive cases were defined as
those with more than 10% of SCC cells exhibiting trans-
forming growth factor-β reactivity [24]. Cytoplasmic and/
or membranous transforming growth factor-β staining was
counted. There were two distinct staining patterns among
the positive cases: one was a “diffuse pattern” in which
most of the carcinoma cells were transforming growth
factor-β positive and the other was a “focal pattern” in
which positive cells were irregularly distributed and
displayed mixed negative and positive areas.
Assessment of the Carcinoma Cells Co-Expressing
Epithelial Membrane Antigen and α-Smooth Muscle Actin
Expression of positive epithelial membrane antigen immu-
noreactivity consisted of purple membranous and occasion-
ally cytoplasmic staining while that of α-smooth muscle
actin consisted of brown cytoplasmic staining. Each section
from the carcinoma group was thoroughly examined at
×400 with special emphasis on the tumor-connective tissue
interface and invasion front for identification of cells that
were simultaneously immunolabeled for both stains. Cases
were assessed qualitatively and assigned as “positive” if
carcinoma cells with these characteristics were found in the
entire section. The double-stained carcinoma cells often
appeared in small islands, clusters or even as isolated cells.
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Differences in the mean percentage of α-smooth muscle
actin-positive myofibroblasts per intersection among the
study groups were analyzed using analysis of variance
(ANOVA) with a log transformation test. Statistical
significance was set at P<0.05. The Statistical Package
for the Social Sciences (SPSS 14, Chicago, IL, USA)
software was used for computations.
Results
Mean % of α-Smooth Muscle Actin-Positive SMF
Per Intersection According to Study Groups
The results are summarized in Table 1.S M Fw e r e
infrequent in cases of premalignant lesions (hyperplasia
and dysplasia) irrespective of the severity of morphological
and cytological changes. The mean percent of SMF in these
Study group Mean ± SD % of stained SMF (range)
Hyperplasia 0.9±0.5 (0.2–2.6)
Mild dysplasia 1.1±0.5 (0.5–2.0)
Moderate-to-severe dysplasia 0.8±0.3 (0.3–1.3)
Squamous cell carcinoma 14.7±12.8
* (1.2–51.4)
Table 1 Mean % of α-smooth
muscle actin-positive SMF/in-
tersection according to study
groups
*P<0.001
Fig. 1 a Epithelial hyperplasia and b moderate-to-severe dysplasia
showing α-smooth muscle actin immunostaining only in smooth
muscle cells within blood vessel walls. No α-smooth muscle actin
immunostaining corresponding to stromal myofibroblasts could be
identified. c Abundance of stromal myofibroblasts in a “network” and,
d “spindle” pattern (anti-α-smooth muscle actin antibody, amino
ethyl-carbazole (AEC) method; a—bar 500μ;b ,c ,d —bar 200μ)
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found among these groups (P>0.05). In contrast, there was
a sharp increase in the mean percent of the SMF in the
carcinoma group (14.7±12.8%). The difference between
the malignant and premalignant groups was highly signif-
icant (P<0.001).
α-Smooth Muscle Actin-Positive SMF Staining Patterns
Immunomorphometric measurements revealed that α-
smooth muscle actin-positive SMF were scarce in cases of
hyperplasia and dysplasia, irrespective of the severity of the
latter (Fig. 1a and b). The appearance of SMF in
remarkable numbers was associated with evidence of
malignancy. Even among cases of carcinoma, however,
the frequency of these cells was not uniform, ranging from
cases with few SMF to cases in which SMF constituted a
major component of all the stroma (Table 2). Five (23%)
cases of carcinoma exhibited a “network” pattern of SMF
with large, usually vesicular nuclei with abundant cyto-
plasm that demonstrated cytoplasmic projections, which
interconnected among neighboring SMF and formed a
network around the carcinoma islands (Fig. 1c). The fine
boundary between the stromal and epithelial compartments
was often breached and a physical connection between the
SMF and the carcinoma cells was apparent. Under these
circumstances, the SMF acquired an epithelioid appearance,
forming syncytial connections between them and the
carcinoma cells. The “network” pattern could be seen
throughout the tumor stroma and was not pronounced at the
invasion front. The “spindle” pattern was observed in 17
(77%) cases. The SMF were aligned in an orderly manner
at the periphery of the tumor islands/nests and there were
distinct borders between these cells and the malignant ones
(Fig. 1d).
Transforming Growth Factor-β Staining Pattern in Cases
of Squamous Cell Carcinoma
Transforming growth factor-β positivity was found in 95%
of the carcinomas, out of which 63% had a “focal” and 32%
had a “diffuse” staining pattern (Table 2, Fig. 2a and b,
respectively). The depth of the tumor and the area of the
invasion front were usually remarkable for the concentra-
tion of transforming growth factor-β-positive carcinoma
cells, even in the “focal” cases. The “diffuse” pattern of
transforming growth factor-β staining became obvious in
cases with a mean percent of SMF of ~8% and higher.
Double Epithelial Membrane Antigen and α-Smooth
Muscle Actin Immunostaining in Cases of Squamous Cell
Carcinoma
Nine (41%) cases of carcinoma that had been submitted to
double immunostaining procedures were designated as
“positive” since they exhibited cells that co-expressed
epithelial membrane antigen and α-smooth muscle actin
(Table 2). Typical epithelial membrane antigen staining was
usually retained in well-differentiated areas, where it was
visualized as a purple, continuous, and slightly granular
membranous stain that highlighted the intercellular regions.
In these areas, the cytoplasm of the carcinoma cells often
had a light purplish-to-pink color. In other less differenti-
ated areas, membranous epithelial membrane antigen
reactivity was reduced and appeared as an interrupted band
with occasional very pale cytoplasmic stain. A pattern of
progressing loss of membranous epithelial membrane
antigen staining was seen at the periphery of the tumor
islands or in small clusters situated within the depth of the
sections and at the invasive front. The cytoplasm of these
cells was light brown and they were barely distinguishable
Table 2 Cases of tongue squamous cell carcinoma according to
increasing values of mean % of SMF and the respective pattern of
distribution of SMF, epithelial membrane antigen (EMA) and α-
smooth muscle actin (SMA) double staining and transforming growth
factor (TGF)-β pattern
Case
no.
Mean %
of SMF
Pattern of
distribution of
SMF
EMA and α-
SMA double
staining
TGF-β
pattern
1 1.2 Spindle + Focal
2 1.3 Spindle + Focal
3 1.8 Spindle − Focal
4 3.7 Spindle − Focal
5 4.1 Spindle − Focal
6 7 Spindle − Focal
7 7.2 Spindle − Focal
8 7.8 Spindle − Diffuse
9 8.75 Spindle − Diffuse
10 10.7 Spindle + Focal
11 11 Spindle − No
Stain
12 11.5 Spindle − Focal
13 12.65 Spindle − Focal
14 13 Spindle − Diffuse
15 13.5 Spindle + Diffuse
16 16.1 Spindle − Focal
17 24.2 Spindle − Diffuse
18 24.4 Network + Focal
19 28.2 Network + Focal
20 28.5 Network + Diffuse
21 33.6 Network + Diffuse
22 51.4 Network + Focal
(+), positive double immunostaining and (−) negative double
immunostaining
Stromal myofibroblasts in tongue dysplastic and malignant lesions 53from the surrounding mesenchymal cells on the basis of
nuclear pleomorphism and hyperchromatism or according
to their connection to a cluster of carcinoma cells that still
maintained some of the epithelial membrane antigen
immunoreactivity. These cells occasionally displayed a
stellate-shaped or fusiform architecture with cytoplasmic
projections, thereby assuming a mesenchymal appearance
(Fig. 3a). In these areas, some of the carcinoma cells—
especially those presenting morphological alterations—
co-expressed epithelial membrane antigen and α-smooth
muscle actin. The former stain had a purple membranous or
cytoplasmic appearance and the latter stain was brown and
cytoplasmic (Fig. 3a and b).
The higher the SMF counts, the more frequent the
“network” distribution of the SMF tended to be, and the
more frequent the presence of carcinoma cells co-
expressing epithelial membrane antigen and α-smooth
muscle actin (Table 2).
Discussion
The results of our study showed that presence of SMF was
associated with carcinoma of the tongue, while these cells
were sparse to absent in pre-malignant lesions. In addition,
we found that tumors were heterogeneous in the extent of
SMF and their pattern of distribution and morphological
features. Indications of an association between squamous
cell carcinoma and SMF were reported in previous studies
that employed cell lines [25] and specimens of squamous
Fig. 3 a Small islands of carcinoma cells at the invading front
showing a stellate-shaped and fusiform architecture with cytoplasmic
projections, some with a fibroblastoid appearance. Remnants of
epithelial membrane antigen staining (purple membranous/cytoplas-
mic stain) disclose their epithelial origin. Brownish cytoplasmic
staining of α-smooth muscle actin is observed in a few foci within
the carcinoma cells (arrows) (anti-epithelial membrane antigen and
anti-α-smooth muscle actin antigen antibodies, Fast-red and 3,3′-
diaminobenzidine (DAB) double immunostaining; bar 50μ). b
Spindle carcinoma cells with remnants of epithelial membrane antigen
staining and an area of brown cytoplasmic stain compatible with α-
smooth muscle actin positivity (thin arrow). A cluster of carcinoma
cells negative for epithelial membrane antigen and positive for α-
smooth muscle actin is seen in the upper left corner (thick arrow) (bar
20μ)
Fig. 2 a Transforming growth factor-β positivity in carcinoma cells
in a “focal” pattern as indicated by arrows; b a “diffuse” pattern (anti-
transforming growth factor-β antibody, amino ethyl-carbazole (AEC)
method; bar 500μ)
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presence of SMF was recently analyzed in a series of
tongue carcinomas versus normal and dysplastic epithelial
lesions from the entire oral mucosa [28]. In that study, in
which frequency of SMF was assessed by a vague semi-
quantitative scale, it was reported that SMF were found
exclusively in carcinoma (~60%) and not in any of the
dysplastic lesions. In contrast, in the present study, tongue
carcinomas were analyzed versus tongue dysplastic lesions
and the frequency of SMF was assessed by a systematic
immunomorphometric method. Accordingly, we found
SMF in all the cases of carcinoma and small numbers of
SMF were also identified in the dysplastic lesions.
Although we investigated a relatively small number of
tumors, not all the examined cases presented a homoge-
neous pattern of SMF. The proportion between an existing
malignancy and SMF ranged from tumors in which the
SMF were incidental to tumors in which they predomi-
nated. Furthermore, the layout of the SMF around the
tumor islands generated different patterns, such that tumors
with fewer SMF usually displayed spindle, delicate SMF
organized in bundles that subtly surrounded the carcinoma
at its periphery, while tumors with an abundance of SMF
often featured epithelioid SMF that amalgamated with the
carcinoma cells and were organized in a syncytium-like,
cellular network. These differences might have an impact
on defining the biological aggressiveness of the tumors,
based on the fact that the SMF are considered as the
biological “factories” for a vast range of mediators that
back up, enhance and promote tumor’s invasion. These
mesenchymal cells are major suppliers of matrix metal-
loproteinases, whose function has been recently extended
and consists not only of degradation of extra-cellular matrix
proteins but also of an active part in tumor initiation,
growth, migration, invasion, formation of metastasis,
angiogenesis and selection of apoptosis-resistant clones
[29]. An association between metalloproteinases and a
more aggressive biological behavior of oral squamous cell
carcinoma and a poorer prognosis has been reported [30,
31].
We also observed a trend wherein the more frequent the
expression of cancer-derived transforming growth factor-β,
the more abundant were the SMF in the adjacent tumor.
This is in accordance with the recognized key role of this
growth factor in the transformation of resident fibroblasts
into myofibroblasts [9, 10]. In addition, it is known that
transforming growth factor-β plays a crucial role, together
with other factors, in another biological process—epithelial-
mesenchymal transition, which has been described as a
physiological process during normal embryogenesis on the
one hand, and in pathological conditions, such as fibrosis
and cancer, on the other hand [12, 13, 32]. In the present
study, some of the SMF had an epithelioid appearance at
the tumor-connective tissue interface, while some of the
carcinoma cells demonstrated a spindle, fibroblastoid
appearance due to a nearly total loss of cohesion with
their neighboring cells. These morphological features
highlighted the blurred boundary between the epithelial
and mesenchymal phenotypes. In addition, double immu-
noreactivity revealed that malignant cells were more
commonly found in tumors that displayed high numbers
of SMF with a “network” pattern of distribution. It seems
that under certain conditions determined by the tumor
needs, the reservoir of SMF (mostly of resident fibroblast
origin) is probably enriched by carcinoma cells that could
undergo epithelial-mesenchymal transition [12, 13, 32, 33].
These observations can be explained, in part, in terms of
the autocrine effect of cancer-derived transforming growth
factor-β. This growth factor interferes with the essential
intercellular epithelial junctional complexes of epithelial
(E)-cadherin and β-catenin, whereby E-cadherin-mediated
sequestration of β-catenin at the cell membrane is
abolished. As a result, β-catenin localizes to the nucleus
and subsequently activates transcriptional factors, such as
Snail, which will ultimately down-regulate E-cadherin
expression and lead to loss of intercellular cohesion [32,
33]. On clinical grounds, reduced expression of E-cadherin
in oral carcinomas has been consistently found to be
associated with an invasive growth pattern and a shortened
5-year survival [19, 34]. In tongue carcinoma, in particular,
low expression of E-cadherin was found to be predictive
for cervical lymph node metastases [35].
Our positive double immunostaining results revealed a
continuum of cells with undistinguishable intercellular
borders, ranging from unmistakably epithelial membrane
antigen-positive carcinoma cells to weakly-to-no epithelial
membrane antigen staining, further to both epithelial
membrane antigen—and α-smooth muscle actin—stained
carcinoma cells, and finally, to strongly α-smooth muscle
actin-stained SMF. This is the first study on human oral
carcinoma that used a double immunostaining method to
show progressive reduction in the expression of epithelial
membrane antigen with concomitant gain of α-smooth
muscle actin. These changes reflect one aspect of the
plasticity in the phenotype of the malignant epithelial
cells, as long as it serves the aim of facilitating local
invasion and metastatic dissemination [11, 16]. In a
previous study in an animal model of tongue carcinoma,
we showed at an ultrastructural level that neoplastic cells at
the tumor-connective tissue interface acquired morphologic
modifications approaching smooth muscle differentiation
by developing a cytoplasmic system of contractile micro-
filaments, probably as part of the epithelial-mesenchymal
transition process [21].
Epithelial membrane antigen was used in this study as a
structural marker for epithelial differentiation [23]. Other
Stromal myofibroblasts in tongue dysplastic and malignant lesions 55studies on epithelial-mesenchymal transition used E-
cadherin as a functional marker for epithelial intercellular
junctional complexes and showed its down-regulation as a
reflection of underlying epithelial-mesenchymal transition,
principally mediated by transforming growth factor-β [12,
32]. Although epithelial membrane antigen and E-cadherin
belong to different classes of molecules with various
functions, a recent study on breast cancer showed restricted
expression of both molecules during the epithelial-
mesenchymal transition process [36].
In summary, the present study was the first to use a
double immunohistochemical technique in human tongue
carcinoma in order to investigate the possibility of an
epithelial-mesenchymal transition process. It has been
shown that SMF, which were almost exclusively associated
with established tongue carcinoma, emerged concomitant
with morphological and immunohistochemical modifica-
tions in the carcinoma cells. Transforming growth factor-β
apparently plays a role in both the emergence of SMF and
in the changes in the malignant cells. This is supported by
the observed trend of its higher expression in cases with
abundant SMF and frequent tumor cells co-expressing
epithelial membrane antigen and α-smooth muscle actin.
The present results justify investigations on a larger scale to
assess whether the frequency of the carcinoma cells
undergoing such modifications may be correlated with
variations in the biological behavior of oral squamous cell
carcinoma and clinical outcomes [37]. Realizing that the
SMF are part of the tumor that contribute to its progression
and that the malignant cells are in a dynamic state of
changing phenotypes toward a mesenchymal differentiation
could help explain the partial response to routine anti-
cancer treatment approaches as is often seen in oral
squamous cell carcinoma, implying that future cancer
therapies would have to target stromal constituents and
should not focus solely on “conventional” cancer cells.
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